Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Podcasts

Headshot of Anthony Watson on a blue background underneath the PopHealth Perspectives logo.
Podcasts
06/29/2023
Anthony Watson, former vice president of Regulatory and Quality at Pear Therapeutics, discusses his recent perspective article explaining FDA regulations as they relate to prescription digital therapeutics (PDTs) and highlights why he...
Anthony Watson, former vice president of Regulatory and Quality at Pear Therapeutics, discusses his recent perspective article explaining FDA regulations as they relate to prescription digital therapeutics (PDTs) and highlights why he...
Anthony Watson, former vice...
06/29/2023
First Report Managed Care
Headshot of Rimal Bera, UC Irvine, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
06/20/2023
Rimal Bera, MD, clinical professor of psychiatry, University of California, Irvine, breaks down major factors in selecting antipsychotics for bipolar disorder and the importance of treatments with high adherence rates.
Rimal Bera, MD, clinical professor of psychiatry, University of California, Irvine, breaks down major factors in selecting antipsychotics for bipolar disorder and the importance of treatments with high adherence rates.
Rimal Bera, MD, clinical...
06/20/2023
Veterans Health Today
Headshot of David Rosmarin, Tufts, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
05/30/2023
David Rosmarin, MD, vice chair of education and research, assistant professor, Tufts Medical Center, walks through findings from TRuE-V, a phase 3 program designed to investigate ruxolitinib's efficacy and safety in patients with vitiligo. 
David Rosmarin, MD, vice chair of education and research, assistant professor, Tufts Medical Center, walks through findings from TRuE-V, a phase 3 program designed to investigate ruxolitinib's efficacy and safety in patients with vitiligo. 
David Rosmarin, MD, vice chair...
05/30/2023
First Report Managed Care
Headshot of Clement Chung, Houston Methodist, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
05/26/2023
Clement Chung, PharmD, MS, BCOP, BCPS, senior clinical pharmacy specialist, hematology and oncology, Houston Methodist West Hospital, reviews the landscape of small molecule inhibitors for chronic lymphocytic leukemia, including important...
Clement Chung, PharmD, MS, BCOP, BCPS, senior clinical pharmacy specialist, hematology and oncology, Houston Methodist West Hospital, reviews the landscape of small molecule inhibitors for chronic lymphocytic leukemia, including important...
Clement Chung, PharmD, MS, BCOP,...
05/26/2023
First Report Managed Care
Headshot of Barbara Konkle, MD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
05/24/2023
Barbara Konkle, MD, professor of medicine, Division of Hematology, University of Washington; research director, Washington Center for Bleeding Disorders; and director, Hemostasis, Platelet Immunology and Genomics Laboratory at Bloodworks...
Barbara Konkle, MD, professor of medicine, Division of Hematology, University of Washington; research director, Washington Center for Bleeding Disorders; and director, Hemostasis, Platelet Immunology and Genomics Laboratory at Bloodworks...
Barbara Konkle, MD, professor of...
05/24/2023
First Report Managed Care
Headshot of Norman Smith on a blue background underneath the PopHealth Perspectives logo.
Podcasts
05/17/2023
Norm Smith, principal payer market research consultant, predicts how payment and patient access strategies may shift once COVID-19 vaccines hit the commercial market and coverage requirements set during the public health emergency expire.
Norm Smith, principal payer market research consultant, predicts how payment and patient access strategies may shift once COVID-19 vaccines hit the commercial market and coverage requirements set during the public health emergency expire.
Norm Smith, principal payer...
05/17/2023
Integrated Healthcare Executive
Headshot of Russell Spjut on a blue background underneath the PopHealth Perspectives logo.
Podcasts
03/30/2023
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, shares insight on the regulatory pathways for emerging PDTs, and discusses some of the work of the Digital Therapeutic Alliance.
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, shares insight on the regulatory pathways for emerging PDTs, and discusses some of the work of the Digital Therapeutic Alliance.
Russell Spjut, PharmD, director,...
03/30/2023
First Report Managed Care
Russell Spjut
Podcasts
03/21/2023
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, offers some insight on the difference between digital therapeutics terminology and the current landscape for these products.
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, offers some insight on the difference between digital therapeutics terminology and the current landscape for these products.
Russell Spjut, PharmD, director,...
03/21/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement